BCR and myeloid leukemia: In the present study, to verify the utility of the CBE system, we first tried to introduce the T315I (ACT to ATT) mutation of the BCR::ABL1 fusion gene, which is the most important BCR::ABL1 mutation, in a human Ph+ myeloid leukemia cell line.